share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SACHS BRUCE I

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SACHS BRUCE I

福泰制药 | 4：持股变动声明-董事 SACHS BRUCE I
美股sec公告 ·  08/02 16:17
Moomoo AI 已提取核心信息
On August 1, 2024, Bruce I. Sachs, associated with Vertex Pharmaceuticals Inc. (VRTX), completed a significant transaction involving the company's common stock. Sachs executed a sale of 5,295 shares at a price of $508.00 per share, resulting in a total transaction value of $2,689,860. This sale followed an acquisition of the same number of shares through the exercise of derivative securities at a price of $125.71 per share. After these transactions, Sachs's direct holdings in Vertex Pharmaceuticals totaled 40,000 shares of common stock.
On August 1, 2024, Bruce I. Sachs, associated with Vertex Pharmaceuticals Inc. (VRTX), completed a significant transaction involving the company's common stock. Sachs executed a sale of 5,295 shares at a price of $508.00 per share, resulting in a total transaction value of $2,689,860. This sale followed an acquisition of the same number of shares through the exercise of derivative securities at a price of $125.71 per share. After these transactions, Sachs's direct holdings in Vertex Pharmaceuticals totaled 40,000 shares of common stock.
2024年8月1日，与福泰制药公司（VRTX）相关联的布鲁斯·I·萨克斯完成了一笔涉及该公司普通股的重要交易。萨克斯以每股508.00美元的价格卖出了5,295股股票，总交易价值为2,689,860美元。此次销售是在以每股125.71美元的价格行使衍生证券获得同样数量的股票之后进行的。在这些交易之后，萨克斯在福泰制药公司的直接持股总数为40,000股普通股。
2024年8月1日，与福泰制药公司（VRTX）相关联的布鲁斯·I·萨克斯完成了一笔涉及该公司普通股的重要交易。萨克斯以每股508.00美元的价格卖出了5,295股股票，总交易价值为2,689,860美元。此次销售是在以每股125.71美元的价格行使衍生证券获得同样数量的股票之后进行的。在这些交易之后，萨克斯在福泰制药公司的直接持股总数为40,000股普通股。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息